ArticleiScience2026

ESM1 drives cisplatin resistance and ferroptosis resistance via ERBB2/FAK/SRC/HSPB1/NF-κB signaling in ovarian cancer.

Juan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.